These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23610138)

  • 1. Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation.
    Heck PB; Müller J; Weber R; Hager A
    Eur J Heart Fail; 2013 Jun; 15(6):644-9. PubMed ID: 23610138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. During treatment protocol for univentricular heart serum levels of natriuretic peptides decrease.
    Eerola A; Jokinen E; Sairanen H; Pihkala J
    Eur J Cardiothorac Surg; 2010 Dec; 38(6):735-40. PubMed ID: 20483629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Range and distribution of NT-proBNP values in stable corrected congenital heart disease of various types.
    Popelová J; Kotaška K; Černý S; Prokopová M; Rubáček M
    Can J Cardiol; 2012; 28(4):471-6. PubMed ID: 22482396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years.
    Robbers-Visser D; Kapusta L; van Osch-Gevers L; Strengers JL; Boersma E; de Rijke YB; Boomsma F; Bogers AJ; Helbing WA
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):89-95. PubMed ID: 19577062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulation.
    Larsson DA; Meurling CJ; Holmqvist F; Waktare JE; Thilén UJ
    Int J Cardiol; 2007 Jan; 114(3):345-51. PubMed ID: 16777247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery.
    Gessler P; Knirsch W; Schmitt B; Rousson V; von Eckardstein A
    J Pediatr; 2006 Mar; 148(3):372-6. PubMed ID: 16615970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide serum levels reflect attrition of the Fontan circulation.
    Wolff D; van Melle JP; Willems TP; Bartelds B; Ploegstra MJ; Hillege H; Ebels T; Berger RMF
    Cardiol Young; 2020 Jun; 30(6):753-760. PubMed ID: 32513314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
    Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
    Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
    Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
    Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
    J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection.
    Koch AM; Zink S; Singer H; Dittrich S
    Eur J Heart Fail; 2008 Jan; 10(1):60-2. PubMed ID: 18068432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.
    Schuuring MJ; Vis JC; van Dijk AP; van Melle JP; Vliegen HW; Pieper PG; Sieswerda GT; de Bruin-Bon RH; Mulder BJ; Bouma BJ
    Eur J Heart Fail; 2013 Jun; 15(6):690-8. PubMed ID: 23361871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
    Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.